sitagliptin and its Impurities

Sitagliptin impurity B is also known as Defluoro Sitagliptin, an impurity of Sitagliptan, an dipeptidyl peptidase-4 (DPP-4) inhibitor for treatment of diabetes mellitus type 2. Reference standards of Sitagliptin API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.

Displaying 21 results for sitagliptin Impurities
Drug Reference Standards & Impurity Synthesis in India
PAI 19 009037

(S)-3-(((4-(2-Aminoethyl)-5-(trifluoromethyl)-4H-1,2,4-triazole-3-carbonyl)oxy)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid

(S)-3-(((4-(2-Aminoethyl)-5-(trifluoromethyl)-4H-1,2,4-triazole-3-carbonyl)oxy)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid

  • Catalogue No.:PAI 19 009037

  • CAS :

    NA

  • Molecular Formula : C16H15F6N5O4

  • Molecular Weight : 455.32

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481095

(R)-Sitagliptin Methyl-Ester Impurity L-Tartaric Acid

(R)-Sitagliptin Methyl-Ester Impurity L-Tartaric Acid

  • Catalogue No.:PA 19 0481095

  • CAS :

    1384431-02-0

  • Molecular Formula : C15H18F3NO8

  • Molecular Weight : 397.3

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481096

N-Methyl Sitagliptin Trifluoroacetate Salt

N-Methyl Sitagliptin Trifluoroacetate Salt

  • Catalogue No.:PA 19 0481096

  • CAS :

    NA

  • Molecular Formula : C19H18F9N5O3

  • Molecular Weight : 535.37

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481097

Propyl 2-(2-amino-3-(2,4,5-trifluorophenyl)propyl)-7-hydroxy-2-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)benzo[d][1,3]dioxole-5-carboxylate

Propyl 2-(2-amino-3-(2,4,5-trifluorophenyl)propyl)-7-hydroxy-2-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)benzo[d][1,3]dioxole-5-carboxylate

  • Catalogue No.:PA 19 0481097

  • CAS :

    NA

  • Molecular Formula : C26H25F6N5O5

  • Molecular Weight : 601.51

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481098

3-Amino-4-(2,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one Phosphate

3-Amino-4-(2,4-difluorophenyl)-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)butan-1-one Phosphate

  • Catalogue No.:PA 19 0481098

  • CAS :

    2988092-90-4

  • Molecular Formula : C16H19F5N5O5P

  • Molecular Weight : 487.32

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481100

(E)-N,N'-dicyclohexyl-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboximidamide

(E)-N,N'-dicyclohexyl-3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carboximidamide

  • Catalogue No.:PA 19 0481100

  • CAS :

    NA

  • Molecular Formula : C19H29F3N6

  • Molecular Weight : 398.48

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481099

(R)-3-Amino-4-(2,4-difluorophenyl)butanoic Acid

(R)-3-Amino-4-(2,4-difluorophenyl)butanoic Acid

  • Catalogue No.:PA 19 0481099

  • CAS :

    1335470-16-0

  • Molecular Formula : C10H11F2NO2

  • Molecular Weight : 215.2

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA BSC 04819988

Sitagliptin Triazole Hydrochloride (BSC)

Sitagliptin Triazole Hydrochloride (BSC)

  • Catalogue No.:PA BSC 04819988

  • CAS :

    762240-92-6

  • Molecular Formula : C6H8ClF3N4

  • Molecular Weight : 228.6

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA BSC 04819989

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid (BSC)

(R)-3-((tert-Butoxycarbonyl)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid (BSC)

  • Catalogue No.:PA BSC 04819989

  • CAS :

    486460-00-8

  • Molecular Formula : C15H18F3NO4

  • Molecular Weight : 333.31

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481101

(R)-3-((Pivaloyloxy)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid

(R)-3-((Pivaloyloxy)amino)-4-(2,4,5-trifluorophenyl)butanoic Acid

  • Catalogue No.:PA 19 0481101

  • CAS :

    NA

  • Molecular Formula : C15H18F3NO4

  • Molecular Weight : 333.31

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481102

Dimethyl 2-(dicyanomethyl)-3,5,6-trifluoroterephthalate

Dimethyl 2-(dicyanomethyl)-3,5,6-trifluoroterephthalate

  • Catalogue No.:PA 19 0481102

  • CAS :

    NA

  • Molecular Formula : C13H7F3N2O4

  • Molecular Weight : 312.2

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481103

(R)-1-(Benzyloxy)-4-(2,4,5-trifluorobenzyl)azetidin-2-one

(R)-1-(Benzyloxy)-4-(2,4,5-trifluorobenzyl)azetidin-2-one

  • Catalogue No.:PA 19 0481103

  • CAS :

    767352-30-7

  • Molecular Formula : C17H14F3NO2

  • Molecular Weight : 321.3

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA STI 090012

1000 ppm N-Nitroso Sitagliptin triazole D4 (10mg/10ml in Methanol)

1000 ppm N-Nitroso Sitagliptin triazole D4 (10mg/10ml in Methanol)

  • Catalogue No.:PA STI 090012

  • CAS :

    NA

  • Molecular Formula : C6H2D4F3N5O

  • Molecular Weight : 225.17

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA STI 090148

7-Nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine-5,5,8,8-d4

7-Nitroso-3-(trifluoromethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazine-5,5,8,8-d4

  • Catalogue No.:PA STI 090148

  • CAS :

    NA

  • Molecular Formula : C6H2D4F3N5O

  • Molecular Weight : 225.17

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481104

Rac-Sitagliptin Hydrochloride

Rac-Sitagliptin Hydrochloride

  • Catalogue No.:PA 19 0481104

  • CAS :

    2309520-11-2

  • Molecular Formula : C16H16ClF6N5O

  • Molecular Weight : 443.78

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481105

N-(4-oxo-4-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)formamide

N-(4-oxo-4-(3-(Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-yl)formamide

  • Catalogue No.:PA 19 0481105

  • CAS :

    NA

  • Molecular Formula : C17H15F6N5O2

  • Molecular Weight : 435.33

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481106

Sitagliptin N-oxide Impurity

Sitagliptin N-oxide Impurity

  • Catalogue No.:PA 19 0481106

  • CAS :

    NA

  • Molecular Formula : C18H16F9N5O4

  • Molecular Weight : 537.34

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA BSC 0481901278

(2R,3S)-2-((tert-Butoxycarbonyl)amino)-3-(3-fluoro-4-nitrophenyl)butanoic Acid (BSC)

(2R,3S)-2-((tert-Butoxycarbonyl)amino)-3-(3-fluoro-4-nitrophenyl)butanoic Acid (BSC)

  • Catalogue No.:PA BSC 0481901278

  • CAS :

    2467738-84-5 (BSC)

  • Molecular Formula : C15H19FN2O6

  • Molecular Weight : 342.32

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481107

3-Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carbaldehyde

3-Trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazine-7(8H)-carbaldehyde

  • Catalogue No.:PA 19 0481107

  • CAS :

    1481965-39-2

  • Molecular Formula : C7H7F3N4O

  • Molecular Weight : 220.16

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481108

Oxo Sitagliptin

Oxo Sitagliptin

  • Catalogue No.:PA 19 0481108

  • CAS :

    NA

  • Molecular Formula : C16H13F6N5O2

  • Molecular Weight : 421.3

Enquire
Details
Drug Reference Standards & Impurity Synthesis in India
PA 19 0481109

1,3-Bis(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)propane-1,3-dione

1,3-Bis(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)propane-1,3-dione

  • Catalogue No.:PA 19 0481109

  • CAS :

    NA

  • Molecular Formula : C15H14F6N8O2

  • Molecular Weight : 452.32

Enquire
Details
Periodic Table- Pharmaffiliates

Calculators
Periodic Table- Pharmaffiliates

Contact us

Ask A Scientist-Pharmaffiliates

Ask a Scientist
General Help

General Help
×
DCAT Week 2026 Pharmaffiliates
×
Analytica Munich 2026 Pharmaffiliates